Equine urinary N-acetyl-β-D-glucosaminidase assay validation and correlation with other markers of kidney injury.

Detection of equine acute kidney injury (AKI) is hindered by limited markers of early renal damage in horses. N-acetyl-β-D-glucosaminidase (NAG), a lysosomal enzyme in renal tubular epithelium released into urine during tubular insult, has shown promise for early identification of AKI in humans and other species. We validated an assay for NAG in equine urine and measured urinary NAG in 7 azotemic and 7 non-azotemic client-owned adult horses. The enzymatic NAG assay was validated using within- and between-run coefficients of variation (CVs), recovery following standard addition, and linearity of dilution. Intra- and inter-run CVs (21% and 3.2%, respectively), average recovery following standard addition (99-109%), and linearity under serial dilution ( = 0.997) were satisfactory. Urine NAG index was significantly correlated with urinary fractional excretion of sodium (FE; ρ = 0.76, < 0.001) and plasma creatinine (ρ = 0.74, = 0.001). Median urine NAG indices were higher in azotemic horses ( = 0.006), in horses with increased urinary FE ( = 0.006), and in horses with increased urine gamma-glutamyl transferase index ( = 0.032). Urine NAG can be measured in horses and shows positive correlation with 2 current renal biomarkers. Additional work is needed to establish normal equine reference intervals and characterize the increase of urine NAG index in horses in relation to tubular injury.